Stroke risk in hypertensive patients with coronary artery disease (CAD): The International Verapamil SR-trandolapril Study (INVEST)

被引：0
|
作者：
Pepine, C [1 ]
Coca, A [1 ]
Messerli, F [1 ]
Benetos, A [1 ]
Zhou, Q [1 ]
Champion, A [1 ]
Cooper-DeHoff, R [1 ]
机构：
[1] Univ Florida, Coll Med, Gainesville, FL USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2005年 / 45卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：424A / 424A
页数：1
相关论文
共 50 条
  • [31] Outcomes Among Hypertensive Patients With Concomitant Peripheral and Coronary Artery Disease Findings From the INternational VErapamil-SR/Trandolapril STudy
    Bavry, Anthony A.
    Anderson, R. David
    Gong, Yan
    Denardo, Scott J.
    Cooper-DeHoff, Rhonda M.
    Handberg, Eileen M.
    Pepine, Carl J.
    HYPERTENSION, 2010, 55 (01) : 48 - 53
  • [32] A PHARMACOGENOMIC GENOME-WIDE ASSOCIATION STUDY FOR ADVERSE CARDIOVASCULAR OUTCOMES IN THE INTERNATIONAL VERAPAMIL SR-TRANDOLAPRIL STUDY (INVEST)
    McDonough, C. W.
    Gong, Y.
    Langaee, T. Y.
    Pepine, C. J.
    Cooper-DeHoff, R. M.
    Johnson, J. A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2014, 95 : S71 - S71
  • [33] Characteristics and Outcomes of Revascularized Patients With Hypertension An International Verapamil SR-Trandolapril Substudy
    Denardo, Scott J.
    Messerli, Franz H.
    Gaxiola, Efrain
    Aranda, Juan M.
    Cooper-DeHoff, Rhonda M.
    Handberg, Eileen M.
    Gong, Yan
    Champion, Annette
    Zhou, Qian
    Pepine, Carl J.
    HYPERTENSION, 2009, 53 (04) : 624 - 630
  • [34] Effects of Verapamil SR and Atenolol on 24-Hour Blood Pressure and Heart Rate in Hypertension Patients with Coronary Artery Disease: An International Verapamil SR-Trandolapril Ambulatory Monitoring Substudy
    Denardo, Scott J.
    Gong, Yan
    Cooper-DeHoff, Rhonda M.
    Farsang, Csaba
    Keltai, Matyas
    Szirmai, Laszlo
    Messerli, Franz H.
    Bavry, Anthony A.
    Handberg, Eileen M.
    Mancia, Giuseppe
    Pepine, Carl J.
    PLOS ONE, 2015, 10 (04):
  • [35] Long-Term Mortality in Hypertensive Patients With Coronary Artery Disease: Results From the US Cohort of the International Verapamil (SR)/Trandolapril Study
    Elgendy, Islam Y.
    Bavry, Anthony A.
    Gong, Yan
    Handberg, Eileen M.
    Cooper-DeHoff, Rhonda M.
    Pepine, Carl J.
    HYPERTENSION, 2016, 68 (05) : 1110 - 1114
  • [36] Beta adrenergic receptors polymorphisms are associated with response to beta-blocker therapy in the international verapamil SR-trandolapril study (invest).
    Gong, Y
    Beitelshees, AL
    Stauffer, LA
    Langaee, TY
    Cooper-DeHoff, RM
    Pepine, CJ
    Johnson, JA
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2006, 79 (02) : P30 - P30
  • [37] A PHARMACOGENOMIC GENOME-WIDE ASSOCIATION STUDY (GWAS) FOR NEW ONSET DIABETES (NOD) IN THE INTERNATIONAL VERAPAMIL SR-TRANDOLAPRIL STUDY (INVEST)
    Chang, S.
    McDonough, C. W.
    Gong, Y.
    Pepine, C. J.
    Johnson, J. A.
    Cooper-DeHoff, R. M.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2014, 95 : S59 - S60
  • [38] Association between CV outcomes, diuretic use and the α-adducin gene;: Results from the INternational VErapamil SR-Trandolapril STudy (INVEST)
    Gerhard, Tobias
    Gong, Yan
    Beitelshees, Amber L.
    Cooper-DeHoff, Rhonda M.
    Johnson, Julie A.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2006, 15 : S17 - S18
  • [39] Association between CV outcomes, diuretic use and the α-adducin gene;: Results from the INternational VErapamil SR-Trandolapril STudy (INVEST)
    Gerhard, T
    Gong, Y
    Beitelshees, AL
    Lobmeyer, M
    Schiefelbein, L
    Langaee, TY
    Cooper-DeHoff, RM
    Johnson, JA
    CIRCULATION, 2005, 112 (17) : U670 - U670
  • [40] A GWAS OF RESISTANT HYPERTENSION IN THE INTERNATIONAL VERAPAMIL SR-TRANDOLAPRIL STUDY (INVEST) AND SECONDARY PREVENTION OF SUBCORTICAL STROKES (SPS3).
    El Rouby, N.
    McDonough, C. W.
    Gong, Y.
    Mcclure, L. A.
    Mitchell, B. D.
    Horenstein, R. B.
    Talbert, R. L.
    Bradford, Y.
    Crawford, D. C.
    Ritchie, M. D.
    Gitzendanner, M. A.
    Takahashi, A.
    Tanaka, T.
    Kubo, M.
    Pepine, C. J.
    Benavente, O. R.
    DeHoff, R. M.
    Johnson, J. A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 101 (S1) : S27 - S28
12345